Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Combined Foot and Mouth Disease (Type O and A), Bovine Viral Diarrhea and Bovine Infectious Rhinotracheitis Inactivated Vaccine
- Development stage
- Preclinical
- Lead developer
- Jinyu Bio-Technology
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The Combined Foot and Mouth Disease (Type O and A), Bovine Viral Diarrhea and Bovine Infectious Rhinotracheitis Inactivated Vaccine is a multivalent veterinary biologic developed by Spirit Jinyu Biological Pharmaceutical (also known as Jinyu Biotechnology). This combination vaccine is designed for the immunization of ruminants, specifically targeting Foot and Mouth Disease (FMD) serotypes O and A, Bovine Viral Diarrhea (BVD), and Bovine Infectious Rhinotracheitis (IBR, caused by Bovine alphaherpesvirus 1). As an inactivated vaccine, it contains killed viral particles that stimulate the host's immune system to produce protective neutralizing antibodies without the risk of viral shedding or disease transmission. The vaccine is currently in the preclinical research stage (IND-enabling) and is intended to streamline livestock vaccination protocols by providing broad-spectrum protection against three major respiratory and systemic viral pathogens in a single product.
- Other names
- Combined FMD (Type O and A) + BVD + IBR Inactivated VaccineFMD (Type O and A) + BVD + IBR Inactivated Vaccine (Spirit Jinyu)Combined Foot and Mouth Disease (Type O and A), Bovine Viral Diarrhea and Bovine Infectious Rhinotracheitis Inactivated Vaccine (Spirit Jinyu)
Beyond the preview
Go deeper on Combined Foot and Mouth Disease (Type O and A), Bovine Viral Diarrhea and Bovine Infectious Rhinotracheitis Inactivated Vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Combined Foot and Mouth Disease (Type O and A), Bovine Viral Diarrhea and Bovine Infectious Rhinotracheitis Inactivated Vaccine.